49 related articles for article (PubMed ID: 16952071)
21. In vivo real-time imaging of nuclear-cytoplasmic dynamics of dormancy, proliferation and death of cancer cells.
Hoffman RM
APMIS; 2008; 116(7-8):716-29. PubMed ID: 18834414
[TBL] [Abstract][Full Text] [Related]
22. Imaging In Mice With Fluorescent Proteins: From Macro To Subcellular.
Hoffman RM
Sensors (Basel); 2008 Feb; 8(2):1157-1173. PubMed ID: 27879758
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent proteins as visible in vivo sensors.
Hoffman RM
Prog Mol Biol Transl Sci; 2013; 113():389-402. PubMed ID: 23244796
[TBL] [Abstract][Full Text] [Related]
24. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
25. Cell migration/invasion assays and their application in cancer drug discovery.
Eccles SA; Box C; Court W
Biotechnol Annu Rev; 2005; 11():391-421. PubMed ID: 16216785
[TBL] [Abstract][Full Text] [Related]
26. In vitro modelling of human tumour behaviour in drug discovery programmes.
Baguley BC; Marshall ES
Eur J Cancer; 2004 Apr; 40(6):794-801. PubMed ID: 15120035
[TBL] [Abstract][Full Text] [Related]
27. Live-cell imaging with EosFP and other photoactivatable marker proteins of the GFP family.
Wiedenmann J; Nienhaus GU
Expert Rev Proteomics; 2006 Jun; 3(3):361-74. PubMed ID: 16771707
[TBL] [Abstract][Full Text] [Related]
28. Molecular-genetic imaging based on reporter gene expression.
Kang JH; Chung JK
J Nucl Med; 2008 Jun; 49 Suppl 2():164S-79S. PubMed ID: 18523072
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. Live cell imaging for target and drug discovery.
Watson P
Drug News Perspect; 2009 Mar; 22(2):69-79. PubMed ID: 19330166
[TBL] [Abstract][Full Text] [Related]
32. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
33. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
34. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
35. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent Proteins as Sensors for Cellular Behavior in Mice.
Hoffman RM
Prog Mol Biol Transl Sci; 2018; 160():29-45. PubMed ID: 30470291
[TBL] [Abstract][Full Text] [Related]
37. The multiple uses of fluorescent proteins to visualize cancer in vivo.
Hoffman RM
Nat Rev Cancer; 2005 Oct; 5(10):796-806. PubMed ID: 16195751
[TBL] [Abstract][Full Text] [Related]
38. Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins.
Hoffman RM
Clin Exp Metastasis; 2009; 26(4):345-55. PubMed ID: 18787963
[TBL] [Abstract][Full Text] [Related]
39. Optical imaging of non-fluorescent nanoparticle probes in live cells.
Wang G; Stender AS; Sun W; Fang N
Analyst; 2010 Feb; 135(2):215-21. PubMed ID: 20098755
[TBL] [Abstract][Full Text] [Related]
40. Strategies for In Vivo Imaging Using Fluorescent Proteins.
Hoffman RM
J Cell Biochem; 2017 Sep; 118(9):2571-2580. PubMed ID: 27564860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
